Medical Director, Heart Valve Program, Massachusetts General Hospital
Cardiology
Dr. Jonathan J. Passeri, MD
|
|
Give Review
Jonathan J. Passeri practices Cardiology. He researched medicine at New York Medical College. Jonathan Passeri is a published doctor and has 41 publications published. The lastest was: 'Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Differential Left Ventricular Outflow Tract Remodeling and Dynamics in Aortic Stenosis.
- Transcatheter Aortic valve replacement and standard therapy in inoperable patients with Aortic stenosis and low EF.
- Continued expansion of the Heart Team concept.
- Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and ...
- Impact of atrial fibrillation on outcomes in patients who underwent transcatheter Aortic valve replacement.
- An intriguing finding in the right atrium.
- Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic Cardiomyopathy.
- Outcomes of Transcatheter and Surgical Aortic Valve Replacement in High-Risk Patients With Aortic Stenosis and Left Ventricular Dysfunction: Results From the Placement...
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
- Severe ischemic Mitral regurgitation despite normally contracting subpapillary myocardium.
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients treated with Anthracyclines, Taxanes and Trastuzumab.
- First experience with transcatheter Valve-in-Valve implantation for a stenotic mitral prosthesis within the United States.
- Case records of the Massachusetts General Hospital. Case 36-2011. A 93-year-old woman with shortness of breath and chest pain.
- Real-time three-dimensional transesophageal echocardiography in patients with secundum Atrial septal defects: outcomes following transcatheter closure.
- Unusual position of a prosthetic mitral Valve.
- sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.
- Echocardiographic assessment of percutaneous patent foramen ovale and Atrial septal defect closure complications.
- Case records of the Massachusetts General Hospital. Case 37-2007. A 47-year-old man with left ventricular dysfunction after Heart transplantation.
- Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after Chronic pressure overload.
- Impact of the multicenter automatic defibrillator implantation trial on clinical practice.
- The Aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter Aortic valve replacement (TAVR).
- Three dimensional echocardiography: approaches and clinical utility.
- Pharmacological inhibition of BLT1 diminishes early abdominal Aneurysm formation.
- Ventricular tachycardia following trans-apical Aortic valve replacement.
- Quadricuspid Aortic Valve: A Report of 12 Cases and a Review of the Literature.
- Imaging of Atrial septal defects: echocardiography and CT correlation.
- Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
- Three-dimensional echocardiography-guided repair of severe paravalvular regurgitation in a bioprosthetic and mechanical mitral Valve.
- Three-dimensional echocardiographic assessment of acquired left ventricular to right Atrial shunt (Gerbode defect).
- Therapeutic angiogenesis: a new treatment approach for ischemic heart Disease--Part II.
- Therapeutic angiogenesis: a new treatment approach for ischemic heart Disease--part I.
- Nitric oxide and cardiac remodeling.
- Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
- Therapeutic angiogenesis: a new treatment modality for ischemic heart Disease.
- Reduced intimal thickening following alpha(v)beta3 blockade is associated with smooth muscle cell apoptosis.
- Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium.
- Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition.
- Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer.
- Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion.
- Apoptosis in human atherosclerosis and restenosis.
Schools
New York Medical College
Mass General Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Education
-
Massachusetts General Hospital -
New York Medical College
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1477534725 | |
| NPPES Provider LastName | PASSERI | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 537.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477534725 |
| Last Name Of The Provider | PASSERI |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
|
Dr. Sharath S. Subramanian, MD |
|
|
Dr. Clarence M. Findley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria T. Vivaldi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary H. Zhang, MD |
|
|
Dr. David P. Faxon, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Adam J. Zucker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick T. Ogara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moussa C. Mansour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel Z. Goldhaber, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Robert O. Blaustein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick L. Ruberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Levine, MD |